BIOHAVEN PHARMACEUTICAL IRELAND DAC

DIFFERENT IN HOW IT DOES IT

Providing online educational information in the academic field of headaches and facial pain;Pharmaceutical preparations for the treatment of headache and facial pain;Patient brochures, booklets, printed informational folders, advertising pamphlets and training materials in the field of headaches and facial pain;

DIFFERENT IN WHAT IT DOES

Providing online educational information in the academic field of headaches and facial pain;Pharmaceutical preparations for the treatment of headache and facial pain;Patient brochures, booklets, printed informational folders, advertising pamphlets and training materials in the field of headaches and facial pain;

DISSOLVING THE LINE BETWEEN ACUTE AND PREVENTATIVE TREATMENT

Pharmaceutical preparations for the treatment of headache and facial pain;Printed Patient brochures, printed booklets, printed informational folders, printed advertising pamphlets, and printed training materials in the field of headaches and facial pain;Providing online educational information about healthcare in the field of headaches and facial pain;

FAST LASTS SIMPLE

Pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia;

NOJECTION

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post- intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use;

NOJECTION

NO INJECTION;Providing medical information in the field of pharmaceuticals; providing medical information in the field of pharmaceuticals that do not require injection, namely, intravenous, intra-muscular, or sub-cutaneous pharmaceuticals; providing medical information in the field of pharmaceuticals by distributing written materials; providing medical information, consultancy and advisory services in the field of pharmaceuticals;

NUGLEA

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post-intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use;

NURTEC

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neurologic illnesses; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia;

NURTEC CONNECT

Printed publications in the nature of brochures, pamphlets, and written articles for medical information and patient support in the field of headache and facial pain;Providing a website featuring financial information about medical benefits and reimbursements available for pharmaceuticals in the field of headache and facial pain; providing online information and financial assistance with insurance benefits and coverage for healthcare providers and patients in the field of headache and facial pain; providing information about insurance coverage and reimbursement for prescription drugs in the field of headache and facial pain; financial administration of a patient assistance program for providing pharmaceuticals for headache and facial pain;Business administration of medication reimbursement programs and services in the field of headache and facial pain; Business administration of patient reimbursement programs in the field of headache and facial pain; Business administration of pharmacy reimbursement programs and services in the field of headache and facial pain;Providing educational and medical information for patients and healthcare providers in the field of headache and facial pain; telemedicine support services in the field of headache and facial pain; dispensing of pharmaceuticals in the field of headache and facial pain;Providing an online non-downloadable software in the nature of a portal for patient support and pharmaceutical reimbursement program services featuring information in the field of headache and facial pain; providing an online non-downloadable software in the nature of a portal for pharmaceutical representatives featuring information in the field of headache and facial pain on physician level aggregated prescription and prior authorization data;

NURTEC ODT

In the statement, line 9, 3-13 should be deleted, and 3-12 should be inserted.;Pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia;ODT;

NURTEC ONESOURCE

Printed publications in the nature of brochures, pamphlets, and written articles for medical information and patient support in the field of headache and facial pain;NURTEC ONE SOURCE;Providing a website featuring financial information about medical benefits and reimbursements available for pharmaceuticals in the field of headache and facial pain; providing online information and financial assistance with insurance benefits and coverage for healthcare providers and patients in the field of headache and facial pain; providing information about insurance coverage and reimbursement for prescription drugs in the field of headache and facial pain; financial administration of a patient assistance program for providing pharmaceuticals for headache and facial pain;Business administration of medication reimbursement programs and services in the field of headache and facial pain; Business administration of patient reimbursement programs in the field of headache and facial pain; Business administration of pharmacy reimbursement programs and services in the field of headache and facial pain;Providing educational and medical information for patients and healthcare providers in the field of headache and facial pain; telemedicine support services in the field of headache and facial pain; dispensing of pharmaceuticals in the field of headache and facial pain;Providing an online non-downloadable software in the nature of a portal for patient support and pharmaceutical reimbursement program services featuring information in the field of headache and facial pain; providing an online non-downloadable software in the nature of a portal for pharmaceutical representatives featuring information in the field of headache and facial pain on physician level aggregated prescription and prior authorization data;

NURTECNOW

Printed publications in the nature of brochures, pamphlets, and written articles for medical information and patient support in the field of headache and facial pain;NURTEC NOW;Providing a website featuring financial information about medical benefits and reimbursements available for pharmaceuticals in the field of headache and facial pain; providing online information and financial assistance with insurance benefits and coverage for healthcare providers and patients in the field of headache and facial pain; providing information about insurance coverage and reimbursement for prescription drugs in the field of headache and facial pain; financial administration of a patient assistance program for providing pharmaceuticals for headache and facial pain;Business administration of medication reimbursement programs and services in the field of headache and facial pain; Business administration of patient reimbursement programs in the field of headache and facial pain; Business administration of pharmacy reimbursement programs and services in the field of headache and facial pain;Providing educational and medical information for patients and healthcare providers in the field of headache and facial pain; telemedicine support services in the field of headache and facial pain; dispensing of pharmaceuticals in the field of headache and facial pain;Providing an online non-downloadable software in the nature of a portal for patient support and pharmaceutical reimbursement program services featuring information in the field of headache and facial pain; providing an online non-downloadable software in the nature of a portal for pharmaceutical representatives featuring information in the field of headache and facial pain on physician level aggregated prescription and prior authorization data;

NURTEK

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post- intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use;

ONE DOSE. ANYTIME. ANYWHERE.

Pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia;

ONE DOSE. RAPID AND SUSTAINED RESULTS.

Providing online educational information in the academic field of headaches and facial pain;Pharmaceutical preparations for the treatment of headache and facial pain;Patient brochures, booklets, printed informational folders, advertising pamphlets and training materials in the field of headaches and facial pain;ONE DOSE;

ONE MIGRAINE. ONE DOSE. ONEDERFUL.

Pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia;

ONEDERFUL

Wholesale distributorships featuring pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of migraine; Wholesale store services featuring pharmaceutical preparations; Wholesale store services featuring pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of migraine;